Executive Branch – Page 5 – Policy & Medicine

Office of Management and Budget To Revise Fraud Rules by Spring

Health IT: White House Office of National Coordinator Issues Surveillance Guidance for Meaningful Use

White House PCAST: Rival Countries Gaining on US Medical Research Spending

President’s Council of Advisors on Science and Technology: Propelling Innovation in Drug Discovery, Development, and Evaluation

FTC Approves Accelerated Recovery Initiative to Reduce Drug Shortages

White House: National Bioeeconomy Blueprint – Encouraging Collaboration

Doc Fix Money from Prevention to Pay Physicians

State of the Union, Bio Pharmaceutical Jobs and Innovation

IRS Releases Proposed ACA Fee Structure for Pharmaceutical Medical Device Manufactures

President to Improve Regulation and Regulatory Review to Spark Innovation